5 June 2024
ReNeuron Group plc
("ReNeuron" or the "Company")
Notice of Creditor's decision on Joint Administrators' Proposals
Further to the announcement of the publication of the Joint Administrators' Proposals on 17 May 2024, ReNeuron Group plc (in administration) (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces that Mark Smith and Stephen Cork of Cork Gully LLP, the Joint Administrators of the Company and of its subsidiaries, ReNeuron Limited, ReNeuron (UK) Limited ReNeuron Holdings Limited (All in Administration) (together the "Group") have filed the "AM07 - Notice of creditor's decision on administrator's proposals" at Companies House. The notice will be published by Companies House in due course.
The notice documents that, at 23:59 hours on 30 May 2024, all decisions were duly approved by creditors.
Further updates on the administration process will be made when appropriate
Enquiries:
| Cork Gully LLP | +44 (0)20 7268 2150 or | ||
| Stephen Cork, Joint Administrator | reneuron@corkgully.com | ||
| Mark Smith, Joint Administrator | | ||
|
| | ||
| ReNeuron | |||
| Iain Ross, Executive Chairman | Via Walbrook PR | ||
| | | ||
| | | ||
| Allenby Capital Limited (Nominated Adviser and Broker) | +44 (0)20 3328 5656 | ||
| James Reeve/George Payne/Dan Dearden-Williams (Corporate Finance) | | ||
| Stefano Aquilino/Kelly Gardiner (Sales & Corporate Broking) | | ||
| | | ||
| Walbrook PR (Media & Investor Relations) | +44 (0)20 7933 8780 or reneuron@walbrookpr.com | ||
| Paul McManus / Alice Woodings | +44 (0)7980 541 893 / +44 (0)7407 804 654 | ||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.